Memorial Sloan Kettering Cancer Center: Blast Crisis trials
The registry lists 18 Blast Crisis studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 0 are open to participants now and 4 have results posted.
Phase 1 8Phase 2 10Phase 3 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell TransplantCompletedNCT00526292Phase 2Results posted
- Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other DiseaseCompletedNCT00423514Phase 1/2Results posted
- Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid CancerCompletedNCT00014495Phase 1/2Results posted
- Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or LymphomaCompletedNCT00002766Phase 3Results posted
- Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaCompletedNCT00081133Phase 1/2
- Pyroxamide in Treating Patients With Advanced CancerCompletedNCT00042900Phase 1
- Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic CancerCompletedNCT00014469Phase 2
- Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer TreatmentCompletedNCT00008359Phase 3
- Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory LeukemiaCompletedNCT00006040Phase 1
- St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for CancerCompletedNCT00005805Phase 3
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous LeukemiaCompletedNCT00005618Phase 2
- Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerCompletedNCT00004065Phase 1
- Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerCompletedNCT00004061Phase 2
- Arsenic Trioxide in Treating Patients With Advanced Hematologic CancerCompletedNCT00003395Phase 1
- Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous LeukemiaCompletedNCT00002890Phase 1
- Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002800Phase 2
- Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002598Phase 2
- Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeCompletedNCT00002502Phase 2